Effectiveness of remdesivir for the treatment of hospitalized COVID-19 persons: A network meta-analysis.
Ontology highlight
ABSTRACT: Several randomized clinical trials (RCTs) that investigated the effectiveness of remdesivir for the treatment of coronavirus disease-2019 (COVID-19) have generated inconsistent evidence. The present study aimed to synthesize available RCT evidence using network meta-analyses (NMAs). Both blinded and open-label RCTs in PubMed database from inception to 7 June 2020 that contained "remdesivir", "Covid-19", and "trial" in the abstracts conducted on hospitalized COVID-19 persons were identified and screened. The studies must have at least one remdesivir arm and evaluated one of the pre-specified outcomes. The outcomes were clinical improvement between days 10 to 15 after randomization and clinical recovery during the follow-up period. The identified literature was supplemented with relatively r
SUBMITTER: Jiang Y
PROVIDER: S-EPMC7461548 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA